Renal Cancer - Results from #5600

Evaluation of Immunogenicity of Nivolumab Monotherapy and its Clinical Relevance in Patients With Metastatic Solid Tumors September 1, 2016

Extended-hours hemodialysis is associated with lower mortality risk in patients with end-stage renal disease September 1, 2016

MEK inhibition abrogates sunitinib resistance in a renal cell carcinoma patient-derived xenograft model August 31, 2016

Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel August 30, 2016

Sunitinib treatment in patients with advanced renal cell cancer: the Brazilian National Cancer Institute (INCA) experience August 30, 2016

Future perspectives in cancer immunotherapy August 30, 2016

Preoperative hydronephrosis is associated with less decline in renal function after radical nephroureterectomy for upper tract urothelial carcinoma August 29, 2016

Cancer diagnostics: the journey from histomorphology to molecular profiling August 19, 2016

Utilization of Sunitinib for Renal Cell Cancer: an Egyptian University hospital experience August 15, 2016

Everolimus affects vasculogenic mimicry in renal carcinoma resistant to sunitinib August 15, 2016

Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development August 12, 2016

Clinicopathological and prognostic significance of survivin expression in renal cancer patients: a meta-analysis August 12, 2016

Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-labeled Pembrolizumab August 10, 2016

The Intratumoral Balance between Metabolic and Immunologic Gene Expression Is Associated with Anti-PD-1 Response in Patients with Renal Cell Carcinoma August 10, 2016

Predictive Immunohistochemical Markers Related to Drug Selection for Patients Treated with Sunitinib or Sorafenib for Metastatic Renal Cell Cancer August 10, 2016

Combined cell surface carbonic anhydrase 9 and CD147 antigens enable high-efficiency capture of circulating tumor cells in clear cell renal cell carcinoma patients August 9, 2016

Immunotherapy of advanced renal cell carcinoma: Current and future therapies August 9, 2016

Second-line treatment for metastatic clear cell renal cell cancer: experts' consensus algorithms August 9, 2016

First-line sunitinib versus pazopanib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium August 8, 2016

Decreased TCL6 expression is associated with poor prognosis in patients with clear cell renal cell carcinoma August 8, 2016

Page 281 of 457